NasdaqCM:AHCO - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	3,736	167	N/A	N/A	5
12/31/2025	3,503	139	150	534	10
12/31/2024	3,314	91	163	523	10
3/31/2024	3,248	-695	53	389	N/A
12/31/2023	3,200	-679	143	481	N/A
9/30/2023	3,122	-427	31	422	N/A
6/30/2023	3,075	42	22	431	N/A
3/31/2023	3,009	40	44	448	N/A
12/31/2022	2,971	63	-18	374	N/A
9/30/2022	2,903	87	66	378	N/A
6/30/2022	2,800	125	20	298	N/A
3/31/2022	2,689	184	79	324	N/A
12/31/2021	2,465	142	72	276	N/A
9/30/2021	2,115	40	68	225	N/A
6/30/2021	1,746	-64	124	232	N/A
3/31/2021	1,361	-131	122	190	N/A
12/31/2020	1,071	-162	156	196	N/A
9/30/2020	858	-91	133	163	N/A
6/30/2020	710	-44	124	145	N/A
3/31/2020	602	-50	45	69	N/A
12/31/2019	530	-21	39	60	N/A
9/30/2019	489	-8	52	68	N/A
6/30/2019	454	8	57	72	N/A
3/31/2019	398	14	61	73	N/A
12/31/2018	345	23	58	68	N/A
12/31/2017	193	10	N/A	46	N/A
12/31/2016	174	-4	N/A	30	N/A

アナリストによる今後の成長予測

収入対貯蓄率: AHCOは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.4% ) よりも高い成長率であると考えられます。

収益対市場: AHCO今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: AHCO今後 3 年以内に収益を上げることが予想されます。

収益対市場: AHCOの収益 ( 5% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: AHCOの収益 ( 5% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: AHCOの自己資本利益率は、3年後には低くなると予測されています ( 9.7 %)。

AdaptHealth 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Consensus EPS estimates fall by 34%

Price target decreased by 8.7% to US$10.50

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Recent updates

AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Chief Technology Officer notifies of intention to sell stock

Insufficient new directors

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

Consensus EPS estimates fall by 34%

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Price target decreased by 8.7% to US$10.50

Rosen Law Firm Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

New minor risk - Share price stability

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Investor sentiment deteriorates as stock falls 16%

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Adapthealth Corp. Announces CEO Changes

Investor sentiment deteriorates as stock falls 17%

Chief Technology Officer notifies of intention to sell stock

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Price target increased by 8.3% to US$17.03

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Investor sentiment improves as stock rises 18%

Adapthealth Corp. Announces CEO Changes

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Consensus EPS estimates increase by 13%, revenue downgraded

First quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 19% to US$17.83

AdaptHealth Corp. Announces Stephen Griggs Not to Seek Re-Election to the Board

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Consensus EPS estimates fall by 35%

Investor sentiment deteriorates as stock falls 32%

Price target decreased by 17% to US$23.60

Full year 2022 earnings: EPS misses analyst expectations

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Insider recently sold US$941k worth of stock

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Insider recently sold US$4.0m worth of stock

AdaptHealth Corp. to Report Q4, 2022 Results on Feb 28, 2023

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet

Insider notifies of intention to sell stock

We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease

Insider recently sold US$1.7m worth of stock

High number of new directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Adapthealth Corp. Updates Earnings Guidance for the Fiscal Year 2022

AdaptHealth Corp. to Report Q3, 2022 Results on Nov 08, 2022

Insider recently sold US$2.4m worth of stock

Insider recently sold US$18m worth of stock

AdaptHealth named a Fresh Pick at Baird after investor day

AdaptHealth: Operating Performance Stretching Up, Valuation Less So

General Counsel & Secretary notifies of intention to sell stock

Consensus forecasts updated

Second quarter 2022 earnings: EPS misses analyst expectations

Price target increased to US$27.75